222 related articles for article (PubMed ID: 26357005)
21. Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts.
Lee J; Putnam AR; Chesier SH; Banerjee A; Raffel C; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Perry A; Solomon DA
Acta Neuropathol Commun; 2018 Sep; 6(1):95. PubMed ID: 30231927
[No Abstract] [Full Text] [Related]
22. Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH.
Talagas M; Marcorelles P; Uguen A; Redon S; Quintin-Roué I; Costa S; Férec C; Morel F; Hieu PD; De Braekeleer M
J Neurooncol; 2012 Sep; 109(2):405-13. PubMed ID: 22825724
[TBL] [Abstract][Full Text] [Related]
23. Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.
Figarella-Branger D; Mokhtari K; Dehais C; Jouvet A; Uro-Coste E; Colin C; Carpentier C; Forest F; Maurage CA; Vignaud JM; Polivka M; Lechapt-Zalcman E; Eimer S; Viennet G; Quintin-Roué I; Aubriot-Lorton MH; Diebold MD; Loussouarn D; Lacroix C; Rigau V; Laquerrière A; Vandenbos F; Michalak S; Sevestre H; Peoch M; Labrousse F; Christov C; Kemeny JL; Chenard MP; Chiforeanu D; Ducray F; Idbaih A;
Neuro Oncol; 2014 Sep; 16(9):1244-54. PubMed ID: 24723566
[TBL] [Abstract][Full Text] [Related]
24. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
25. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
Sahm F; Reuss D; Koelsche C; Capper D; Schittenhelm J; Heim S; Jones DT; Pfister SM; Herold-Mende C; Wick W; Mueller W; Hartmann C; Paulus W; von Deimling A
Acta Neuropathol; 2014 Oct; 128(4):551-9. PubMed ID: 25143301
[TBL] [Abstract][Full Text] [Related]
26. Biomarker-driven diagnosis of diffuse gliomas.
Appin CL; Brat DJ
Mol Aspects Med; 2015 Nov; 45():87-96. PubMed ID: 26004297
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
Singh VY; Chacko G; Chacko AG; Rajshekhar V
Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451
[TBL] [Abstract][Full Text] [Related]
29. Analysis of CIC-associated CpG island methylation in oligoastrocytoma.
Sahm F; Lass U; Herold-Mende C; von Deimling A; Hartmann C; Mueller W
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):831-6. PubMed ID: 23521081
[TBL] [Abstract][Full Text] [Related]
30. Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status.
Katsetos CD; Del Valle L; Geddes JF; Aldape K; Boyd JC; Legido A; Khalili K; Perentes E; Mörk SJ
J Neuropathol Exp Neurol; 2002 Apr; 61(4):307-20. PubMed ID: 11939586
[TBL] [Abstract][Full Text] [Related]
31. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG
Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis identified genes associated with a favorable prognosis in oligodendrogliomas.
Liu Y; Hu H; Zhang C; Wang Z; Li M; Jiang T
Genes Chromosomes Cancer; 2016 Feb; 55(2):169-76. PubMed ID: 26542540
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
Yang P; Kollmeyer TM; Buckner K; Bamlet W; Ballman KV; Jenkins RB
Cancer; 2005 Jun; 103(11):2363-72. PubMed ID: 15834925
[TBL] [Abstract][Full Text] [Related]
34. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.
Johnson DR; Diehn FE; Giannini C; Jenkins RB; Jenkins SM; Parney IF; Kaufmann TJ
AJNR Am J Neuroradiol; 2017 Apr; 38(4):678-684. PubMed ID: 28126746
[TBL] [Abstract][Full Text] [Related]
35. IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.
Miyake Y; Fujii K; Nakamaura T; Ikegaya N; Matsushita Y; Gobayashi Y; Iwashita H; Udaka N; Kumagai J; Murata H; Takemoto Y; Yamanaka S; Ichimura K; Tateishi K; Yamamoto T
J Neuropathol Exp Neurol; 2021 Feb; 80(3):247-253. PubMed ID: 33432322
[TBL] [Abstract][Full Text] [Related]
36. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted.
Yasuda T; Nitta M; Komori T; Kobayashi T; Masui K; Maruyama T; Sawada T; Muragaki Y; Kawamata T
Neuropathology; 2018 Feb; 38(1):41-46. PubMed ID: 28812310
[TBL] [Abstract][Full Text] [Related]
37. Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity.
Chittaranjan S; Chan S; Yang C; Yang KC; Chen V; Moradian A; Firme M; Song J; Go NE; Blough MD; Chan JA; Cairncross JG; Gorski SM; Morin GB; Yip S; Marra MA
Oncotarget; 2014 Sep; 5(17):7960-79. PubMed ID: 25277207
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression.
Ferrer-Luna R; Mata M; Núñez L; Calvar J; Dasí F; Arias E; Piquer J; Cerdá-Nicolás M; Taratuto AL; Sevlever G; Celda B; Martinetto H
J Neurooncol; 2009 Dec; 95(3):343-354. PubMed ID: 19597701
[TBL] [Abstract][Full Text] [Related]
39. Loss of chromosome 1p/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker.
Buckley PG; Alcock L; Heffernan J; Woods J; Brett F; Stallings RL; Farrell MA
J Neuropathol Exp Neurol; 2011 Mar; 70(3):177-82. PubMed ID: 21293300
[TBL] [Abstract][Full Text] [Related]
40. Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.
Roux A; Tauziede-Espariat A; Zanello M; Peeters S; Zah-Bi G; Parraga E; Edjlali M; Lechapt E; Shor N; Bellu L; Berzero G; Dormont D; Dezamis E; Chretien F; Oppenheim C; Sanson M; Varlet P; Capelle L; Dhermain F; Pallud J
Neuro Oncol; 2020 Jul; 22(7):993-1005. PubMed ID: 32025725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
